drugset / Trial / NCT01297179

A Study to Evaluate the Possible Effects of Taking Mirabegron While Taking a Contraceptive Pill

NCT01297179

Phase 1 Completed 30 enrolled Astellas Pharma Inc
RandomizedCrossoverTriple-blindBasic science

Summary

The objective of this study is to determine the effect of multiple doses of mirabegron on the pharmacokinetics of an oral contraceptive.

Timeline

Start
2008-10
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirabegron Other / unclassified Oral
Subject ethinyl estradiol Small molecule Oral

Indications

No indication recorded.